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Abstract: Dermacoccus abyssi strain MT1.1T is a piezotolerant actinobacterium that was isolated from
Mariana Trench sediment collected at a depth of 10898 m. The organism was found to produce
ten dermacozines (A-J) that belonged to a new phenazine family and which displayed various
biological activities such as radical scavenging and cytotoxicity. Here, we report on the isolation and
identification of a new dermacozine compound, dermacozine M, the chemical structure of which was
determined using 1D and 2D-NMR, and high resolution MS. A whole genome sequence of the strain
contained six secondary metabolite-biosynthetic gene clusters (BGCs), including one responsible for
the biosynthesis of a family of phenazine compounds. A pathway leading to the biosynthesis of
dermacozines is proposed. Bioinformatic analyses of key stress-related genes provide an insight into
how the organism adapted to the environmental conditions that prevail in the deep-sea.
Keywords: Mariana Trench; Dermacoccus abyssi MT1.1T; dermacozines; genome sequencing;
biosynthetic gene clusters
1. Introduction
Recently, the search for new natural products that can be developed as resources for healthcare
has been focused on the isolation of micro-organisms from extreme biomes on the premise that
harsh environmental conditions give rise to unique diversity which in turn is a source of novel
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chemistry [1,2]. Culture-dependent strategies show that taxonomically novel actinobacteria isolated
from deep-sea sediments and hyper-arid desert soils are a remarkably good source of new bioactive
natural products [2–4]. A case in point is Dermacoccus abyssi MT1.1T, a novel piezotolerant strain,
isolated from sediment collected from the Challenger Deep of the Mariana Trench in the Pacific Ocean [5],
which produces a new ten-membered family of phenazines, the dermacozines [6,7]. Dermacoccus abyssi
MT1.1T (family Dermacoccaceae, order Micrococcales), is a Gram-positive actinobacterium, which forms
coccoid cells (diameter 0.8–1.5 µm) that occur in irregular clusters. It grows well on glucose-yeast
extract agar (GYEA) forming cream to pale-yellow, circular, convex, smooth, glistening colonies after 5
days of incubation at temperatures between 10 and 37 ◦C, with optimal growth at 28 ◦C. It grows well
at 40 MPa as well as at normal atmospheric pressure in glucose-yeast extract broth [8]. Extremotolerant
and extremophilic actinobacteria are in great demand in the search for new secondary metabolites for
drug discovery using state-of-the-art technologies, notably genome mining [9].
Phenazines belong to a large class of nitrogen-containing heterocyclic redox-active pigments of
bacterial origin. They are produced by Gram-negative bacteria (e.g., Pseudomonas), and Gram-positive
bacteria (e.g., Streptomyces) and by archaeal Methanosarcina species, and exhibit antibiotic, antitumor,
insecticidal, and antiparasitic activities [10–12]. The core structure of phenazines consists of a pyrazine
ring (1,4-diazobenzene) showing two annulated benzenes. Several phenazines, the dermacozines, are
produced by D. abyssi MT1.1T and MT1.2 (Figure 1). These are highly pigmented compounds belonging
to a class of reduced phenazine-based marine products which contain a N-methyl bridge connecting
two or more fused benzene rings [6,13]. Ten members of this family, dermacozines A–J, were identified
and found to display various biological activities, such as radical scavenging and cytotoxicity against
the leukemia cell line K562. Our ongoing studies on D. abyssi MT1.1T resulted in the detection and
characterization of an additional compound, dermacozine M. In this report, we describe the isolation
and structural determination of this new dermacozine. In addition, the generation of a whole genome
sequence of D. abyssi MT1.1T led to the discovery of the phenazine biosynthetic gene cluster and
the identification of candidate genes necessary for bacterial adaptation to extreme environmental
conditions that prevail in the deep sea.
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carbons were identified as one NH2 group [NH2-12 (δH 7.99, 8.93)]; and one NH group carboxylic 
imide moiety [NH-14 (δH 11.34)]. The connectivity between the spin systems was established from 
key 1H-13C HMBC correlations, including correlations from H-2 to C-4/C-11; from H-4 to C-2; from 
H-2/H-4 to C10a/C-24, thereby clearly defining the positions of the carboxamide group and the 
benzoyl moiety on C-1 and C-3, respectively. Furthermore, correlations from the methyl group CH3-
23 to C-4a and C-5a accompanied with NOESY correlation with H-4 (Figure 2) confirmed its 
position relative to C-4a and C-5a. HMBC correlations from H-8 to C-6/C-9a together with a 
correlation from H-9 to C-7 confirmed the positions of C-6, C-7, and C-9a relative to the H-8, H-9 
spin system. Finally, observed HMBC correlations of H-8, H-18/H-22 to C-16 confirmed the position 
of a monosubstituted benzene ring at C-16. Accordingly, the structure of 11 was identified as 3- 
benzoyl dermacozine E [6], the latter was named dermacozine M. 
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2. Results and Discussion
2.1. Compound Identification
Dermacozine M (11) was isolated as a navy-blue powder. HRESIMS showed pseudomolecular ion
peaks at m/z 501.1550 [M + H]+, 523.1364 [M + Na]+, 1001.3031 [2M + H]+, and 1023.2848 [2M + Na]+
consistent with a molecular formula of C30H20O4N4, ∆ = −1.4 ppm, which requires 23 degrees of
unsaturation. The UV/Vis spectrum showed absorption maxima at 590, 380, 285, and 245 nm.
13C NMR shifts for compound 11 obtained from overlaid HMBC and 1H-13C HSQC spectra
exhibited one methyl signal at δH 3.69 (CH3-23), fourteen aromatic methines grouped by 1H-1H COSY
into four spin systems (Figure 2) comprising H-2, H-4 [δH 8.21 (d, 1.8), 8.13 (d, 1.8)]; H-8, H-9 [δH 7.25 (d,
9.7), 7.35 (d, 9.7)]; and two monosubstituted benzene rings H-18 – H-22 [δH 7.33 (2H, dd, 7.5, 1.3), 7.49
(2H, t, 7.5), 7.44 (1H, td, 7.5, 1.3)], and H-26 – H-30 [δH 7.85 (2H, dd, 7.5, 1.5), 7.64 (2H, dd, 7.5, 1.5), 7.76
(1H, m)] (Table 1). Additionally, fourteen quaternary carbon atoms were identified from 1H-13C HSQC
and 1H-13C HMBC as well as 1H-13C HSQC and a 2 Hz long range 1H-13C HMBC spectra, including
three carbonyls C-11, C-15, and C-24 (δC 165.5, 161.7, and 194.4); no correlation was observed either
to/or from the C-13 carbonyl. Comparison with previously published dermacozines and simulation
with the ACD Lab neural network algorithm showed that the C-13 chemical shift was predicted to
appear at δC 161.9. Moreover, four carbons were identified next to nitrogen atoms C-4a, C-5a, C-9a,
and C-10a (δC 134.1, 139.2, 152.3, and 137.4); six olefinic carbons C-1, C-6, C-7, C-16, C-17, and C-25 (δC
131.0, 100.8, 139.4, 123.4, 133.9, and 136.5) were also detected. Furthermore, HMBC correlations were
not observed with C-3; chemical shift simulation with ACD lab software identified the chemical shift
of C-3 at δC 134.9, which is compatible with data for previously published dermacozines [6,13].
The 1H–13C HSQC NMR spectrum showed that three protons which lacked correlation to carbons
were identified as one NH2 group [NH2-12 (δH 7.99, 8.93)]; and one NH group carboxylic imide moiety
[NH-14 (δH 11.34)]. The connectivity between the spin systems was established from key 1H-13C
HMBC correlations, including correlations from H-2 to C-4/C-11; from H-4 to C-2; from H-2/H-4 to
C10a/C-24, thereby clearly defining the positions of the carboxamide group and the benzoyl moiety on
C-1 and C-3, respectively. Furthermore, correlations from the methyl group CH3-23 to C-4a and C-5a
accompanied with NOESY correlation with H-4 (Figure 2) confirmed its position relative to C-4a and
C-5a. HMBC correlations from H-8 to C-6/C-9a together with a correlation from H-9 to C-7 confirmed
the positions of C-6, C-7, and C-9a relative to the H-8, H-9 spin system. Finally, observed HMBC
correlations of H-8, H-18/H-22 to C-16 confirmed the position of a monosubstituted benzene ring at
C-16. Accordingly, the structure of 11 was identified as 3- benzoyl dermacozine E [6], the latter was
named dermacozine M.
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Table 1. 1H (600 MHz) and 13C NMR (150 MHz) data (in DMSO-d6) for compound 11.
no. 11
δC, mult. δH, mult (J in Hz)
1 131.0, C -
2 127.2, CH 8.21, d (1.8)
3 134.9†, C -
4 119.8, CH 8.13, d (1.8)
4a 134.1, C -
5a 139.2, C -
6 100.8, C -
7 139.4, C -
8 130.1, CH 7.25, d (9.7)
9 134.8, CH 7.35, d (9.7)
9a 152.3, C -
10a 137.4, C -
11 165.5, C -
12 a. 7.99, brsb. 8.93, brs
13 161.9 †, C -
14 11.34, brs
15 161.7, C -
16 123.4, C -
17 133.9, C -
18 131.1, CH 7.33, dd (7.5, 1.3)
19 127.9, CH 7.49, t (7.5)
20 127.7, CH 7.44, td (7.5, 1.3)
21 127.9, CH 7.49, t (7.5)
22 131.1, CH 7.33, dd (7.5, 1.3)
23 45.6, CH3 3.69, s
24 194.4, C -
25 136.5, C -
26 129.6, CH 7.85, dd (7.5, 1.5)
27 128.6, CH 7.64, td (7.5, 1.5)
28 133.2, CH 7.76, m
29 128.6, CH 7.64, td (7.5, 1.5)
30 129.6, CH 7.85, dd (7.5, 1.5)
† Shifts were not observed—calculated chemical shifts were made using the ACD Labs Neural Network algorithm.
The calculated UV spectrum was simulated using a time-dependent DFT (TDDFT) calculation.
Dermacozine M was initially submitted to a conformational search performed in the Macromodel
module implemented in Maestro Quantum mechanical software (Schrödinger). Sixteen conformers
were found within a 3.5 kcal/mol energy threshold from a global minimum. All these conformers
were geometrically optimized, and frequency calculated by using a density functional theory (DFT)
method at the HSEH1PBE/cc-pVDZ level (see computational details in the experimental section). In
all calculations, the ethanol environment was simulated using the Polarizable Continuum Model,
(PCM) by the integral equation formalism variant (IEFPPCM) as is implemented in Gaussian 09. The
resulting UV spectra were combined by Boltzmann weighting to give a composite spectrum [14–16].
The spectra showed an UV/vis maximum at 592.6 nm (Figure 3), a result in perfect agreement with the
experimental data.
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Figure 3. Dermacozine M: (a) Conformers obtained from the conformational search; (b) Theoretical 
UV spectra. 
2.2. Genome Sequencing and Annotation 
The whole genome sequencing reads of D. abyssi MT1.1T were generated by using an Ion 
Torrent PGM instrument, 316v2 chips, and a 400-bp sequencing kit. Assembly of the reads with the 
Torrent SPAdes plugin (v. 3.1.0) and CLC Genomics Workbench de novo assembly programs 
resulted in 55 contigs over 1 kb and up to 340.6 kb in size. The total size of the genome assembly 
was 3,160,906 bp with 122.46 × fold coverage and a 68.12% G + C content. The size and G + C 
content of the studied strain are in a good agreement with those of D. abyssi HZAU 226, the only 
other member of the species for which a full genome sequence is available. 
The genome sequence was annotated using the NCBI prokaryotic genome annotation pipeline 
[17–19], as well as RAST [16], which predicted 3335 genes, 2959 CDSs, 163 pseudogenes, 6 rRNAs, 
49 tRNA, 3 ncRNA, and 82 frameshifted genes within the 55 contigs in D. abyssi MT1.1T (Table 2). 
Table 2. General features of the D. abyssi MT1.1 genome. 
Features D. abyssi (MT1.1) 
Assembly size, bp  3,160,906 
No. of contigs 55 
G + C 68.1 
Fold coverage 122.46× 
Percentage of bases 99.7% 
N50 159983 
L50 7 
Genes 3,335 
CDs 2,959 
Pseudogenes 163 
Pseudogenes (frameshifted) 82 
Protein encoding genes 2810 
rRNA 6 
tRNA 49 
ncRNAs   3 
Accession no. NZ_QWLM00000000 
2.3. Secondary Metabolite-Biosynthetic Gene Clusters 
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Figure 3. Dermacozine M: (a) Conformers o t i e from the conformational search; (b) Theoretical
UV spectra.
2.2. Genome Sequ nci g and Annotation
The whole genome sequencing reads of D. abyssi MT1.1T were generated by using an Ion Torrent
PGM instrument, 316v2 chips, and a 400-bp sequencing kit. Assembly of the reads with the Torrent
SPAdes plugin (v. 3.1.0) and CLC Genomics Workbench de novo assembly programs resulted in 55
contigs over 1 kb and up to 340.6 kb in size. The total size of the genome assembly was 3,160,906 bp
with 122.46 × fold coverage and a 68.12% G + C content. The size and G + C content of the studied
strain are in a good agreement with those of D. abyssi HZAU 226, the only other member of the species
for which a full genome s quence is available.
The genome sequence was annotated using the NCBI prokaryotic ge ome annotation
pipeline [17–19], as well as RAST [16], which predicted 3335 genes, 2959 CDSs, 163 pseudogenes,
6 rRNAs, 49 tRNA, 3 ncRNA, and 82 frameshifted genes within the 55 contigs in D. abyssi MT1.1T
(Table 2).
Table 2. General features of the D. abyssi MT1.1 genome.
Features D. abyssi (MT1.1)
Assembly size, bp 3,160,906
No. of contigs 55
G + C 68.1
Fold coverage 122.46×
Percentage of bases 99.7%
N50 159983
L50 7
Genes 3,335
CDs 2,959
Pseudogenes 163
Pseudogenes (frameshifted) 82
Protein encoding genes 2810
rRNA 6
tRNA 49
ncRNAs 3
Accession no. NZ_QWLM00000000
2.3. Secondary Metabolite-Biosynthetic Gene Clusters
The draft genome of D. abyssi MT1.1T was examined for the presence of secondary
metabolite-biosynthetic gene clusters using antiSMASH 5.1.0 [20]. The results showed the presence
of a nonribosomal peptide synthetase (NRPS) in addition to five potential secondary metabolite
gene clusters responsible for the biosynthesis of ectoine, siderophores, a bacteriocin, terpenes, and
a phenazine.
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Phenazine Biosynthetic Gene Clusters
A putative phenazine biosynthetic gene cluster (Phz BGC) responsible for the biosynthesis of
dermacozines was identified in the genome of D. abyssi MT1.1T. The analysis of this cluster revealed
the presence of twenty genes involved in the dermacozine biosynthetic pathway, which belonged to
four main functional groups, including core, additional, regulatory, and other biosynthetic genes of
various catalytic functions (Figure 4). The predicted functions of the genes are listed in Table 3.
Dermacozine biosynthesis, like that of most phenazine compounds, starts via the shikimate
pathway. Shikimic acid is converted to chorismic acid that is subsequently transformed to 2-amino-2-
deoxyisochorismic acid (ADIC) necessary for the formation of the core structure of phenazines (Figure 5).
Six genes comprising the phzBCEFGH cluster are involved in the biosynthesis of dermacozines. PhzE
and PhzF probably catalyze the sequential formation of 2-amino-2-desoxyisochorismic acid (ADIC) and
6-amino-5-oxocyclohex-2-ene-1-carboxylic acid (AOCHC) [21]; PhzB and -G are believed to be involved
in the oxidation/aromatization of initial tricyclic species [22]. Furthermore, PhzH (asparagine synthase)
catalyzes transamidation leading to the formation of 5,10-dihydrophenazine-1,6-dicarboxamide (PCN)
from 5,10-dihydrophenazine-1,6-dicarboxylic acid (PCA) [23]. Additional biosynthetic genes, such as
those encoding an oxidoreductase thio-amide protein, as well as alpha/beta hydrolase with an esterase
function and a group of regulatory proteins, were also detected.Mar. Drugs 2019, 17, x FOR PEER REVIEW 7 of 18 
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Table 3. Predicted function of genes detected in the phenazine biosynthetic gene cluster (Phz BGC) of D. abyssi MT1.1T (antiSMASH 5.1.0 and GenBank).
No. Locus Tag Nucleotide(nt) Protein
Accession
Number Function Homologue
Accession
Number Identity
Coverage
Percentage
E
Value
2 D1832_RS13610 846
PhzF family
phenazine
biosynthesis
isomerase
WP_118914810 DHHAisomerase
PhzF family phenazine
biosynthesis isomerase
[Streptomyces purpureus]
WP_019884027 76.95% 99% 6e-150
3 D1832_RS15170 669 Hypothetical protein WP_147362718 Unknownactivity
Hypothetical protein
D1832_13610
[Dermacoccus abyssi]
RHW43994 99.28% 62% 1e-98
4 D1832_RS13620 1125
3-deoxy-7-
phosphoheptulonate
synthase (PhzC)
WP_118914924 DAHPsynthase
3-deoxy-7-
phosphoheptulonate synthase
[Streptomyces sp. uw30]
WP_147995366 67.65% 99% 6e-176
5 D1832_RS13625 1896
Phenazine-specific
anthranilate synthase
(PhzE)
WP_118914814 ADICsynthase
Phenazine-specific anthranilate
synthase component I
[Streptomyces purpureus]
WP_019884038 69.54% 98% 0.0
6 D1832_RS13630 306
Hypothetical protein
(biosynthetic-additional
thio_amide)
WP_118914815 Oxidoreductase YdhR family protein[Streptomyces sp. uw30] WP_147993498 62.11% 93% 9e-33
7 D1832_RS13635 621
Pyridoxamine
5’-phosphate oxidase
(PhzG)
WP_118914817
Phenazine-1,6-
dicarboxylic
acid (PDC)
formation
Pyridoxal 5’-phosphate
synthase [Streptomyces sp.
uw30]
WP_147993497 60.68% 100% 3e-78
8 D1832_RS13640 1842 Asparagine synthase(PhzH) WP_118914818
Asparagine
synthase
(glutamine-
hydrolyzing)
activity
Asparagine synthase
(Glutamine-hydrolyzing)
[Streptomyces thermocarboxydus]
WP_137209574 79.13% 99% 0.0
9 D1832_RS13645 444
Phenazine
biosynthesis protein:
phzB
WP_118914868
6-amino-5-
oxocyclohex-2-
ene-1-
carboxylic
acid
(AOCHC)
dimerization
phenazine biosynthesis protein
[Streptomyces thermocarboxydus] WP_137209661 83.67% 100% 3e-91
10 D1832_RS13650 993
WYL
domain-containing
protein
WP_118914820
Ligand-binding
regulatory
domain
WYL domain-containing
protein [Streptomyces
glaucescens]
WP_043504928 69.78% 97% 2e-145
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Table 3. Cont.
No. Locus Tag Nucleotide(nt) Protein
Accession
Number Function Homologue
Accession
Number Identity
Coverage
Percentage
E
Value
11 D1832_RS13655 402 RidA family protein WP_118914821
Enamine/imine
deaminase
activity
RidA family protein
[Streptomyces exfoliatus] WP_037644077 80.30% 99% 2e-71
12 D1832_RS13660 492
DUF488
domain-containing
protein
WP_118914870 Unknown
DUF488 domain-containing
protein [Streptosporangiaceae
bacterium YIM 75507]
WP_119930667 68.12% 98% 5e-70
13 D1832_RS13665 393
DUF4186
domain-containing
protein
WP_118914823 Unknown
DUF4186 domain-containing
protein [Nocardia
suismassiliense]
WP_107655452 81.15% 93% 2e-66
14 D1832_RS13670 1617 Hypothetical protein WP_118914825 Asparaginaseactivity
Asparaginase [Blastococcus sp.
DSM 44205] SDE71699 61.57% 100% 0.0
15 D1832_RS13675 344
TraR/DksA family
transcriptional
regulator
WP_118913125 Transcriptionalregulation
DNA-binding protein
[Micropruina glycogenica] WP_105185941 62.92% 77% 2e-24
16 D1832_RS13680 360 VOC family protein WP_118912933
Dioxygenase
and
glyoxalase
VOC family protein
[Propionibacterium freudenreichii] WP_013161949 92.50% 100% 2e-76
17 D1832_RS13685 309
TetR/AcrR family
transcriptional
regulator
WP_118914637 Transcriptionalregulation
TetR/AcrR family
transcriptional regulator
[Streptomyces mirabilis]
WP_075033331 73.53% 99% 1e-41
18 D1832_RS13690 702 Alpha/beta hydrolase WP_118914826
Carboxylic
ester
hydrolase
activity
(esterase)
Alpha/beta hydrolase
[Streptacidiphilus jeojiense] WP_030267495 47.84% 98% 2e-64
19 D1832_RS13695 195 Hypothetical protein WP_147362719 Unknown
Hypothetical protein
D1832_13690 [Dermacoccus
abyssi]
RHW44004 98.44% 100% 2e-36
20 D1832_RS13700 579
TetR/AcrR family
transcriptional
regulator
WP_118914830 Transcriptionalregulator
TetR family transcriptional
regulator [Actinotalea sp.
HO-Ch2]
WP_149205434 58.19% 91% 1e-54
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Additional analysis of the D. abyssi MT1.1T genome revealed the presence of genes encoding
additional proteins that might be involved in the biosynthesis of dermacozines, including
shikimate kinase, dehydroquinate synthase, and chorismate synthase for shikimic acid biosynthesis;
aminotransferase, enoyl-CoA hydratase, 3-hydroxyacyl-CoA dehydrogenase, and thiolase for
benzoyl-CoA biosynthesis; acyltransferase that putatively catalyzes the condensation of benzoyl-CoA
with the tricyclic phenazine structure (Table 4).
Table 4. Additional proteins implicated in biosynthesis of dermacozines identified in the genome of D.
abyssi MT1.1T.
Protein AA Accession Number Function
Shikimate kinase 213 WP_118912523 Shikimic acid biosynthesis
Dehydroquinate synthase 354 WP_118912522 Shikimic acid biosynthesis
Chorismate synthase 407 WP_118912574 Shikimic acid biosynthesis
Enoyl-CoA hydratase 265 WP_118912167 β-hydroxyphenylpropionyl-CoA biosynthesis
3-hydroxyacyl-CoA
dehydrogenase 704 WP_118913237
β-ketophenylpropionyl-CoA
biosynthesis
Thiolase family protein 405 WP_047311533 Benzoyl-CoA biosynthesis
Pyridoxal phosphate-dependent
aminotransferase 405 WP_047311611 Transamination
Acyltransferase family protein 667 WP_118912475 Acyl condensation
Class I SAM-dependent DNA
methyltransferase 912 WP_118914833 Methylation
2.4. Genomic Insights Into Adaptation Strategies
The Mariana Trench system is a non-accretionary convergent plate found between the Philippine
Sea and subducting Pacific plates. The Mariana Trench is characterized by its elevated hydrostatic
pressure (depth 10,915 to 10,920 m), low temperature (approx. ∼1 ◦C), high salinity, low oxygen, nitrate,
nitrite, and phosphate concentrations and by low pH [6].
Stress associated genes reported in other bacteria were sought from the genome sequence of D.
abyssi MT1.1T to get insight into adaptation for such environments. A detailed discussion of the genes
involved in stress responses is provided below.
2.4.1. Cold Shock Response
Cold shock affects cell growth, the rates of DNA, RNA, and protein synthesis, as well as
cell membrane structure and function in deep-sea habitats. D. abyssi MT1.1T has genes encoding
cold-shock proteins and cold-shock inducible proteins such as ClpB, GroL, GroES, and DEAD box
RNA helicase (Table S1). The ability of deep-sea bacteria to produce a variety of cold shock inducible
proteins is essential for low temperature adaptation of many deep-sea psychrotrophic bacteria, such as
Pseudomonas putida and Shewanella violacea [24–26]. Furthermore, a gene encoding DEAD/DEAH-box
RNA helicase is induced by cold shock and has been shown to be implicated in cellular processes such
as ribosome biogenesis, translation initiation and termination, and cell growth and differentiation.
At low temperature, DEAD/DEAH-box RNA helicases play important roles in cold shock response and
cold adaptation by destabilizing RNA duplexes to promote translation initiation, and by participating
in assembly of the 50S ribosomal subunit [27].
2.4.2. Osmotic Stress Response
In deep-sea habitats, such as in the Mariana Trench, bacteria are exposed to high pressure
conditions, which affect the extracellular environment leading to disturb internal osmotic balances.
The accumulation of different small organic molecules (compatible solutes) is one of the ways for cells
to readjust the balance of internal osmotic pressures. Mining of the D. abyssi MT1.1T genome revealed
Mar. Drugs 2020, 18, 131 11 of 17
the presence of many genes associated with the synthesis and accumulation of such solutes, including
betA, opuA for choline, and glycine/betaine regulation and transport. Another predicted gene encodes
the Aquaporin Z protein that mediates the transport of water molecules across cell membranes [28]
(Table S1). The presence of these genes indicates the important role played by compatible solutes, such
as osmoregulators, to overcome osmotic stress in deep sea environments.
D. abyssi MT1.1T grows well at 40 MPa [8]. Mining of the D. abyssi genome revealed a
number of genes required for pressure-sensing and pressure-adaptation in other piezotolerant and
piezophilic bacteria. These genes encode terminal oxidases, such as aspartate β-D-semialdehyde
dehydrogenase asd, cytochrome bd biosynthesis proteins cydAB, thiol reductant ABC exporter subunit
cydCD, malate dehydrogenase mdh, and a single-stranded DNA binding protein ssb were discovered
in piezotolerant/piezophilic bacteria such as Photobacterium profundum strain SS9 and Shewanella
species [29] (Table S1).
In high pressure environments, the transport of compounds such as amino acid is reduced, leading
to upregulation of certain transporters to counteract significant inhibition of amino acids uptake into
cells at high pressure [30]. Different types of ABC transporter permeases were detected in the D. abyssi
MT1.1T genome including ABC transporter permease, an amino acid ABC transporter permease,
and a branched-chain amino acid ABC transporter permease that is up-regulated at high pressure
to compensate for the reduction of transportation functionality [31]. Another significant group of
proteins involved in protein export across the outer membrane are the export proteins SecD and SecF.
Strains lacking these proteins have been shown to be cold and high pressure-sensitive [31].
Many biological processes, such as membrane transport, intracellular signaling, metabolic electron
transport, protein–protein interactions, and gene regulation, are dependent on the dynamic state and
physical structure of membranes hence the maintenance of biological membranes in cold temperature
and high pressure conditions is essential for bacterial growth and survival [32].
2.4.3. Oxidative Stress Response
The D. abyssi MT1.1T genome contained copies of antioxidant enzyme-encoding genes that
counteract the effect of reactive oxygen species (ROS) generated at low temperatures, such as superoxide
dismutase, catalase, thioredoxin, thioredoxin-disulfide reductase, peroxiredoxin, peroxiredoxin (OsmC
family), NAD(P)H-quinone oxidoreductase, alkyl hydroperoxide reductase, glutathione S-transferase
(family protein), arsenate reductase, and glutaredoxin (family proteins), all of which have the ability to
repair damage caused to proteins and other cell components by ROS [31] (Table S2).
2.4.4. Respiration
The D. abyssi MT1.1T genome contains many genes encoding terminal oxidases for aerobic
respiration, such as cytochrome d ubiquinol oxidase subunit I, II genes cydAB, and cytochrome c
oxidase of the aa3-type (Table S2). Cytochrome d oxidase cyd exhibits a high affinity for O2, thereby
facilitating respiration under microaerobic conditions, whereas aa3-type oxidase complexes show a low
affinity for O2 and work only at high O2 tensions [24]. In addition, a number of terminal reductases
(terminal electron acceptors) and distinct dehydrogenase encoding genes involved in respiratory chains
were identified, such as those encoding arsenate reductase ArsC, ferredoxin reductase, as well as
NADH-quinone oxidoreductase (NADH dehydrogenase-1) Nuo, glycerol-3-phosphate dehydrogenase,
lactate dehydrogenase, and formate dehydrogenase. Moreover, multiple copies of genes encoding
succinate dehydrogenases that can be used as electron donating systems under low oxygen conditions
were detected in the genome of D. abyssi MT1.1T (Table S2) [33]. This strain also has the capacity
to produce many cytochrome oxidase complexes of different affinities for oxygen, implying that
respiratory reductases and dehydrogenases allow the strain to adapt to different oxygen levels.
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2.4.5. Cell Wall/Membrane Alteration
Maintaining cell membranes in a liquid crystalline state is considered to be one of the most
crucial requirements for organisms living in cold environments. Psychrophilic bacteria tend to retain
membrane fluidity and functionality by incorporating lower melting point branched chain and/or
polyunsaturated fatty acids (PUFAs), such as such as docosahexaenoic acid (DHA) and eicosapentaenoic
acid (EPA) in their membrane lipids. Interestingly, analysis of the genome of D. abyssi MT1.1T revealed
the presence of genes encoding groups of enzymes involved in the synthesis of long chain PUFAs,
such as acyl-CoA desaturase, enoyl-ACP reductase, enoyl-CoA hydratase (ECH), 3-hydroxyacyl-CoA
dehydrogenase, long-chain fatty acid-CoA ligase, acyl dehydratase, phosphopantetheinyl transferase,
UDP-N-acetylglucosamine 1-carboxyvinyltransferase, 3-oxoacyl-ACP reductase (FabG), ketoacyl-ACP
synthase (FabH), enoyl (FabI), as well as phytoene/squalene synthase that is linked to membrane
fluidity at low temperatures in the psychrophilic bacteria [34–36] (Table S3).
2.4.6. Carbon Starvation and Storage
In nutrient-limiting conditions, such as in deep-sea ecosystems, organisms need to store carbon.
The genome of the D. abyssi MT1.1T exhibited the presence of genes encoding the carbon starvation
protein A CstA, in addition to the glycogen synthesis protein GlgA, the glycogen debranching enzyme
GlgX, and glycogen/starch/alpha-glucan phosphorylase, which is responsible for the breakdown of these
storage molecules. The genome also included multiple copies of genes encoding for carbon-nitrogen
hydrolase and carbonic anhydrase proteins essential for efficient CO2 fixation [31,37,38] (Table S3).
2.4.7. Remineralization of Organic Matter
Since there is a dearth of organic matter in deep-sea habitats, global thermohaline circulation plays
a crucial role in transferring nutrients from primary production sources. Accordingly, deep-sea bacteria
respond quickly to the presence of organic matter by producing enzymes that convert extracellular
complex organic compounds to easily metabolized molecules.
The D. abyssi MT1.1T genome included genes encoding extracellular enzymes responsible for
remineralization of organic matter (Table S4), including a group of proteases and polysaccharases able
to decompose proteinaceous and polysaccharide materials derived from phytoplankton and dead
marine vertebrates that sink to deep-sea floors [39,40].
With increased depth in the ocean, the level of organic nitrogen in deep-sea habitats is decreased.
Access of D. abyssi MT1.1T to nitrogen might be facilitated by the expression of purine and allantoin
utilization genes.
Interestingly, almost all the candidate genes necessary for bacterial adaptation to extreme
environmental conditions relevant to this study (Tables S1–S4) are also present in published genome
sequences of other Dermacoccus strains, namely D. abyssi HZAU266 and D. nishinomiyaensis NCTC11039T,
which are not extremophilic. This suggests that the ability of the strain to live under stress conditions
not only depends on the presence or absence of stress genes but also on their expression levels,
which in turn are regulated by complicated metabolic processes that may differ between organisms.
Consequently, molecular mechanisms which determine how organisms cope with environmental
conditions that prevail in the deep-sea habitat are worthy of further study.
3. Materials and Methods
3.1. General Experimental Procedures
NMR spectra were recorded in DMSO-d6 (δC 39.5, δH 2.50) on a Bruker 600 MHz NMR
spectrometer AVANCE III HD (Billerica, MA, USA) operating with a liquid N2 cooled ‘Prodigy’
cryoprobe. High-resolution ESI-MS data were obtained using a Thermo Instruments MS system (LTQ
XL/LTQ Orbitrap Discovery, Thermo Scientific, San Jose, CA, USA) coupled to a Thermo Instruments
HPLC system (Accela PDA detector, Accela PDA autosampler and Accela pump). HPLC separations
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were carried out using a Sunfire reversed phase column (C18, 5 µm, 250 × 10 mm) and an Agilent 1100
series gradient pump monitored using a DAD G1315 variable-wavelength UV detector.
3.2. Microorganism
Dermacoccus abyssi strain MT1.1T was isolated from sediment collected from the Challenger Deep
of the Mariana Trench (142◦12′372′′ E; 11◦19′911′′ N) at 10,898 m by using the remotely unmanned
operated submarine “Kaiko”, during dive number 74, on 21/05/1998 [8].
3.3. Fermentation Conditions
For small-scale fermentation, a colony was scooped with a loop and seeding cultures prepared in
100 mL Erlenmeyer flasks with 25 mL GYE medium (yeast extract 4 g, d-glucose 4 g, MilliQ water 1 L
adjusted to pH 7.0) after incubation for five days at 28 ◦C with agitation at 150 rpm.
For large-scale fermentation, six 2 L Erlenmeyer flasks, each of them containing 1000 mL of ISP2
medium (yeast extract 4 g, D-glucose 10 g, malt extract 10 g, MilliQ water 1 L) supplemented with 35
g/L ocean salt (H2Ocean + Pro Formula with trace elements, The Aquarium Solution Ltd., Hainault
Industrial Estate, Ilford Essex, UK) was inoculated with 1.5 mL of the first stage seed culture and
incubated at 28 ◦C with agitation at 150 rpm for 14 days.
3.4. Purification of Dermacozine M
Harvested fermentation broth from strain MT1.1T (6 L) was mixed with 50 g/L Diaion HP20 resin
(>250 um, Alfa Aesar, Ward Hill, MA, USA) for 24 h in a shaker at 28 ◦C and a setting of 150 rpm.
The HP20 resin was eluted with methanol (3× 500 mL) and then with acetone. Successive methanol and
acetone extracts were combined and concentrated under reduced pressure, yielding the crude material
(6758 mg) which was partitioned with liquid–liquid extraction (Kupchan method) [41]. The crude
material was suspended in H2O and extracted with an equal volume of dichloromethane three times.
The dichloromethane layer was dried then subsequently dissolved in 90% methanol and 10% H2O
solution. This solution was subjected to extraction with an equal volume of n-hexane. The reminder of
the methanol-H2O (90%/10%) solution, after n-hexane extraction, was adjusted to 50% methanol–50%
H2O solution. This solution was extracted with an equal volume of dichloromethane three times.
The dichloromethane fraction (379.9 mg) was subjected to standard silica gel (Fluorochem, 60A 40–63U
MW = 60.083, Derbyshire, UK) column chromatography (Quickfit XA42 29/32, 19/26, 19 mm × 500 mm,
Fisher Scientific, Loughborough, UK) with a 90% dichloromethane and 10% methanol mobile phase.
The first visible colored band upon silica chromatography yielded a pure navy blue compound, namely
dermacozine M (11) (2.8 mg).
Dermacozine M (5): bluish violet amorphous powder, 2.8 mg; UV: λmaxCH3OH+H2O 590, 380, 285,
245 nm; HRESIMS (m/z 501.1550 [M + H]+, 523.1364 [M + Na]+, 1001.3031 [2M + H]+, 1023.2848
[2M + Na]+, MF = C30H20N4O4, 500.1485, ∆ = −1.4 ppm); 1H and 13C NMR data (DMSO-d6), see
Table 1.
3.5. Computational Calculations
Conformational searches were performed by using the Macromodel module implemented in
Maestro Quantum mechanical software [14]. The OPLS 2005 force field with methanol as solvent
was used, and torsional enhanced sampling with 1000 or 10,000 steps was fixed using an energy
window of 3.5 kcal/mol. Molecular geometry optimizations were performed at the DFT theoretical
level using the Gaussian 09W package firstly with a B3LYP/6-31G(d) combination and then with
HSEH1PBE/cc-pVDZ auto /IEFPCM model (ethanol as solvent) for energy and frequency calculations.
After removing redundant conformers and those with imaginary frequencies, theoretical Boltzmann
energy population-weighted UV was calculated by using PBEPBE/6-311++(3d,2p) with 24 states [15].
A graphical theoretical UV curve was obtained using the open software SpecDis V.1.71 (Berlin, Germany,
2017, https:/specdis-software.jimdo.com) [16].
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3.6. Genome Sequencing Information
3.6.1. DNA Extraction and Genome Sequencing
Genomic DNA was extracted from D. abyssi MT1.1T following the modified CTAB method cited
in current protocols in molecular biology [42]. A NEB Next Fast DNA Fragmentation and Library
Preparation Kit (New England Biolabs) for Ion Torrent instruments was used to generate a sequencing
library according to the manufacturer’s protocol. After enzymatic fragmentation, end repair and
ligation to A1 and P2 adapters, followed by PCR amplification of 490–500 bp fragments were isolated
and analyzed using the BioAnalyser 2100 and High Sensitivity DNA kit (Agilent Technologies LDA
UK Limited, Cheshire, UK). The library was used for template preparation using the IonTorrent One
Touch system and an Ion PGM Hi-Q™ View OT2 Kit, followed by recovery of positive Ion Sphere
Particles using the One Touch ES enrichment system. The sequencing reaction was conducted using
the IonTorrent PGM instrument, 316v2 chips and Ion PGM Hi-QTM View Sequencing Kit with 850
sequencing flows, according to manufacturer’s instructions (Life Technologies Limited, Paisley, UK).
3.6.2. Detection of the Gene Clusters
The whole genome sequence of D. abyssi MT1.1T was mined using antiSMASH 5.1.0 (“Antibiotic
and Secondary Metabolites Analysis Shell”) [20], while the NCBI GenBank annotation pipeline and
RAST were used for the detection of proteins and genes responsible for adaptation.
3.6.3. Genbank Accession Number
This Whole Genome Shotgun sequence was deposited at DDBJ/ENA/GenBank under accession
number QWLM00000000. The version described in this paper is version QWLM01000000.
4. Conclusions
Dermacoccus abyssi strain MT1.1T is an example of a deep marine strain with a genome that harbors
six uncharacterized secondary metabolite-biosynthetic gene clusters. The strain produces a unique
family of phenazines, the dermacozines, including dermacozine M, which was extracted in the present
study from a fermentation broth and its structure determined using NMR, high resolution MS, and by
structural comparison with previously published dermacozines. Subsequently, data mining of the
whole genome sequence of the strain lead to the detection of the phenazine BGC and genes involved
in the biosynthesis of the unique dermacozines. The genome of D. abyssi strain MT1.1T contained
five secondary metabolite BGCs in addition to the phenazine one, the analysis of which may lead
to the discovery of additional novel bioactive secondary metabolites. Bioinformatic analyses of the
genome lead to the identification of putative stress-related genes that provided an insight into how the
organism may cope with the environmental conditions that prevail in deep-sea habitats.
Supplementary Materials: The following are available online at http://www.mdpi.com/1660-3397/18/3/131/s1,
Figures S1–S9: Structure, LC MS and NMR spectra of dermacozine M (11) in DMSO-d6, Figure S10: ACD Labs
13C chemical shift prediction of 11, Table S1: Putative cold shock and osmotic stress response genes, Table S2:
Oxidative stress response and respiration-related genes, Table S3: Genes responsible for cell wall/membrane
alteration and carbon starvation, Table S4: Putative organic matter-hydrolyzing enzymes.
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